scholarly article | Q13442814 |
P356 | DOI | 10.3109/02713683.2014.894079 |
P698 | PubMed publication ID | 24787678 |
P2093 | author name string | Li Huang | |
Min Chen | |||
Zheng Zhang | |||
Jian Ma | |||
Jian Ge | |||
Xiaoning Li | |||
Lei Xi | |||
Weizhong Zhang | |||
Lihong Duan | |||
Daping Quan | |||
P2860 | cites work | Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model | Q28730203 |
The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. | Q30988191 | ||
Antifibrotics and Wound Healing in Glaucoma Surgery | Q31141978 | ||
Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery | Q33823508 | ||
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin | Q34552385 | ||
Chitosan-based nanostructures: a delivery platform for ocular therapeutics. | Q37643883 | ||
Intraoperative episcleral versus postoperative topical application of mitomycin-C for trabeculectomies | Q42679457 | ||
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery | Q43254741 | ||
Microscopic and spectroscopic evaluation of novel PLGA-chitosan Nanoplexes as an ocular delivery system. | Q45433967 | ||
Polyhydroxyethylaspartamide-based micelles for ocular drug delivery. | Q45998936 | ||
Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats | Q46840768 | ||
P433 | issue | 10 | |
P304 | page(s) | 982-988 | |
P577 | publication date | 2014-04-30 | |
P1433 | published in | Current Eye Research | Q5195042 |
P1476 | title | CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery | |
P478 | volume | 39 |
Q96431759 | Effect of connective tissue growth factor gene editing using adeno-associated virus-mediated CRISPR-Cas9 on rabbit glaucoma filtering surgery outcomes | cites work | P2860 |
Search more.